These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 27456924)

  • 1. Comparison of CHOP versus VEPA Therapy in Patients with Lymphoma Type of Adult T-cell Leukemia.
    Shimamoto Y; Suga K; Shimojo M; Nishimura J; Nawata H; Yamagughi M
    Leuk Lymphoma; 1990; 2(5):335-40. PubMed ID: 27456924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic results and prognostic factors of patients with advanced non-Hodgkin's lymphoma treated with VEPA or VEPA-M.
    Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ichimaru M; Ogawa M; Kimura I; Tominaga S
    J Clin Oncol; 1988 Jan; 6(1):128-41. PubMed ID: 2891797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Major prognostic factors of adult patients with advanced B-cell lymphoma treated with vincristine, cyclophosphamide, prednisone and doxorubicin (VEPA) or VEPA plus methotrexate (VEPA-M).
    Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ogawa M; Tominaga S; Tsugane S; Minato K
    Jpn J Clin Oncol; 1988 Jun; 18(2):113-24. PubMed ID: 3379782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia.
    Shimoyama M; Ota K; Kikuchi M; Yunoki K; Konda S; Takatsuki K; Ichimaru M; Tominaga S; Tsugane S; Minato K
    J Clin Oncol; 1988 Jul; 6(7):1088-97. PubMed ID: 2899140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in Prognostic Factors between Diffuse Non-Hodgkin's Lymphoma and Lymphoma Type of Adult T-Cell Leukemia.
    Matsuzaki M; Shimamoto Y; Ono K; Sano M; Tokioka T; Suga K; Sueoka E; Tokunaga O; Suzuki H; Sato H; Shimoyama M; Yamaguchi M
    Leuk Lymphoma; 1990; 1(5-6):327-33. PubMed ID: 20394561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination chemotherapy with adriamycin, cyclophosphamide, vincristine, prednisolone (VEPA) in non-Hodgkin's lymphoma, with special reference to correlation of surface phenotype with response and survival].
    Chubachi A; Miura AB; Yamaguchi A; Nishimura S
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2057-63. PubMed ID: 3293535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult T-cell leukemia/lymphoma in Jamaica and its relationship to human T-cell leukemia/lymphoma virus type I-associated lymphoproliferative disease.
    Gibbs WN; Lofters WS; Campbell M; Hanchard B; LaGrenade L; Clark J; Cranston B; Saxinger C; Gallo R; Blattner WA
    Princess Takamatsu Symp; 1984; 15():77-90. PubMed ID: 6100652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (VEPA) for non-Hodgkin's lymphoma].
    Saaki A; Yokomatsu Y; Kojima K; Yoshikawa T; Sannomiya Y; Tatsumi J; Hashimoto K; Park K; Kawarabayashi K; Yoshikawa C
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):65-9. PubMed ID: 3753642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences Between Long- and Short-Term Survivors with Lymphoma Type of Adult T-Cell Leukemia.
    Shimamot Y; Suga K; Igarashi H; Nishimura J; Nawata H; Yamaguchi M
    Leuk Lymphoma; 1990; 2(5):301-5. PubMed ID: 27456920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A comparative study of VEPA and ACOMEP-BD regimen for the patients with non-Hodgkin's lymphoma].
    Kanamori H; Tanabe J; Okamoto R; Tamura T; Fujita H; Murata T; Hashimoto Y; Harano H; Matsuzaki M; Motomura S
    Rinsho Ketsueki; 1993 Jun; 34(6):697-704. PubMed ID: 8366571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma.
    Mori M; Kitamura K; Masuda M; Hotta T; Miyazaki T; Miura AB; Mizoguchi H; Shibata A; Saito H; Matsuda T; Masaoka T; Harada M; Niho Y; Takaku F
    Int J Hematol; 2005 Apr; 81(3):246-54. PubMed ID: 15814336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical outcomes of 106 patients with peripheral T-cell lymphoma treated by standard CHOP regimen].
    Huang HQ; Peng YL; Lin XB; Sun XF; Lin TY; Xia ZJ; Li YH; Cai QQ; He YJ; Jiang WQ; Guan ZZ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1443-7. PubMed ID: 15566653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].
    Hou M; Li L; Qiu M; Yan X; Zhu J; Gou HF
    Ai Zheng; 2005 Apr; 24(4):461-4. PubMed ID: 15820070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent hepatic involvement in adult T cell leukemia: comparison with non-Hodgkin's lymphoma.
    Yamada Y; Kamihira S; Murata K; Yamamura M; Maeda T; Tsukasaki K; Jubash T; Atogami S; Sohda H; Taguchi T; Tomonaga M
    Leuk Lymphoma; 1997 Jul; 26(3-4):327-35. PubMed ID: 9322895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics of and response to combination chemotherapy and subsequent application of international prognostic index in non-Hodgkin's lymphoma--an experience from a medical center in Southern Taiwan.
    Hsieh CI; Su WC; Chien CH; Cuo YL; Chen TY; Kao RH; Tsao CJ
    Kaohsiung J Med Sci; 1996 Feb; 12(2):69-82. PubMed ID: 8709176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Differences between Lymphoma and Leukemia Type of Adult T-cell Leukemia.
    Shimamoto Y; Yamaguchi M; Miyamoto Y; Yamaguchi J; Kuribayashi N; Sato H; Nishimura J; Nawata H; Kozuru M; Shimoyama M
    Leuk Lymphoma; 1990; 1(2):101-12. PubMed ID: 27463815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.